Stephen J Greene1, Emily C O'Brien2, Robert J Mentz1, Nancy Luo1, N Chantelle Hardy3, Warren K Laskey4, Paul A Heidenreich5, Chun-Lan Chang6, Stuart J Turner6, Clyde W Yancy7, Adrian F Hernandez1, Lesley H Curtis2, Pamela N Peterson8, Gregg C Fonarow9, Bradley G Hammill10. 1. Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, North Carolina. 2. Duke Clinical Research Institute, Durham, North Carolina; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina. 3. Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina. 4. Division of Cardiology, University of New Mexico School of Medicine, Albuquerque, New Mexico. 5. Department of Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, California. 6. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. 7. Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 8. Division of Cardiology, Anschutz Medical Campus, University of Colorado Denver, Aurora, Colorado; Division of Cardiology, Denver Health Medical Center, Denver, Colorado. 9. Ahmanson-UCLA Cardiomyopathy Center, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California. 10. Duke Clinical Research Institute, Durham, North Carolina; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina. Electronic address: brad.hammill@duke.edu.
Abstract
BACKGROUND: Surveys of patients with cardiovascular disease have suggested that "home-time"-being alive and out of any health care institution-is a prioritized outcome. This novel measure has not been studied among patients with heart failure (HF). OBJECTIVES: This study sought to characterize home-time following hospitalization for HF and assess its relationship with patient characteristics and traditionally reported clinical outcomes. METHODS: Using GWTG-HF (Get With The Guidelines-Heart Failure) registry data, patients discharged alive from an HF hospitalization between 2011 and 2014 and ≥65 years of age were identified. Using Medicare claims, post-discharge home-time over 30-day and 1-year follow-up was calculated for each patient as the number of days alive and spent outside of a hospital, skilled nursing facility (SNF), or rehabilitation facility. RESULTS: Among 59,736 patients, 57,992 (97.1%) and 42,153 (70.6%) had complete follow-up for home-time calculation through 30 days and 1 year, respectively. The mean home-time was 21.6 ± 11.7 days at 30 days and 243.9 ± 137.6 days at 1 year. Contributions to reduced home-time varied by follow-up period, with days spent in SNF being the largest contributor though 30 days and death being the largest contributor through 1 year. Over 1 year, 2,044 (4.8%) patients had no home-time following index hospitalization discharge, whereas 8,194 (19.4%) had 365 days of home-time. In regression models, several conditions were associated with substantially reduced home-time, including chronic obstructive pulmonary disease, renal insufficiency, and dementia. Through 1 year, home-time was highly correlated with time-to-event endpoints of death (tau = 0.72) and the composite of death or HF readmission (tau = 0.59). CONCLUSIONS: Home-time, which can be readily calculated from administrative claims data, is substantially reduced for many patients following hospitalization for HF and is highly correlated with traditional time-to-event mortality and hospitalization outcomes. Home-time represents a novel, easily measured, patient-centered endpoint that may reflect effectiveness of interventions in future HF studies.
BACKGROUND: Surveys of patients with cardiovascular disease have suggested that "home-time"-being alive and out of any health care institution-is a prioritized outcome. This novel measure has not been studied among patients with heart failure (HF). OBJECTIVES: This study sought to characterize home-time following hospitalization for HF and assess its relationship with patient characteristics and traditionally reported clinical outcomes. METHODS: Using GWTG-HF (Get With The Guidelines-Heart Failure) registry data, patients discharged alive from an HF hospitalization between 2011 and 2014 and ≥65 years of age were identified. Using Medicare claims, post-discharge home-time over 30-day and 1-year follow-up was calculated for each patient as the number of days alive and spent outside of a hospital, skilled nursing facility (SNF), or rehabilitation facility. RESULTS: Among 59,736 patients, 57,992 (97.1%) and 42,153 (70.6%) had complete follow-up for home-time calculation through 30 days and 1 year, respectively. The mean home-time was 21.6 ± 11.7 days at 30 days and 243.9 ± 137.6 days at 1 year. Contributions to reduced home-time varied by follow-up period, with days spent in SNF being the largest contributor though 30 days and death being the largest contributor through 1 year. Over 1 year, 2,044 (4.8%) patients had no home-time following index hospitalization discharge, whereas 8,194 (19.4%) had 365 days of home-time. In regression models, several conditions were associated with substantially reduced home-time, including chronic obstructive pulmonary disease, renal insufficiency, and dementia. Through 1 year, home-time was highly correlated with time-to-event endpoints of death (tau = 0.72) and the composite of death or HF readmission (tau = 0.59). CONCLUSIONS: Home-time, which can be readily calculated from administrative claims data, is substantially reduced for many patients following hospitalization for HF and is highly correlated with traditional time-to-event mortality and hospitalization outcomes. Home-time represents a novel, easily measured, patient-centered endpoint that may reflect effectiveness of interventions in future HF studies.
Authors: Javed Butler; Milton Packer; Stephen J Greene; Mona Fiuzat; Stefan D Anker; Kevin J Anstrom; Peter E Carson; Lauren B Cooper; Gregg C Fonarow; Adrian F Hernandez; James L Januzzi; Mariell Jessup; Rita R Kalyani; Sanjay Kaul; Mikhail Kosiborod; JoAnn Lindenfeld; Darren K McGuire; Marc S Sabatine; Scott D Solomon; John R Teerlink; Muthiah Vaduganathan; Clyde W Yancy; Norman Stockbridge; Christopher M O'Connor Journal: Circulation Date: 2019-12-16 Impact factor: 29.690
Authors: Adam Simning; Jessica Orth; Jinjiao Wang; Thomas V Caprio; Yue Li; Helena Temkin-Greener Journal: J Am Geriatr Soc Date: 2020-04-15 Impact factor: 5.562
Authors: Katherine C Lee; Jocelyn Streid; Dan Sturgeon; Stuart Lipsitz; Joel S Weissman; Ronnie A Rosenthal; Dae H Kim; Susan L Mitchell; Zara Cooper Journal: J Am Geriatr Soc Date: 2020-02-11 Impact factor: 5.562
Authors: Rajeshwari Nair; Yubo Gao; Mary S Vaughan-Sarrazin; Eli Perencevich; Saket Girotra; Ambarish Pandey Journal: J Gen Intern Med Date: 2021-04-26 Impact factor: 6.473
Authors: Adam Simning; Jessica Orth; Thomas V Caprio; Yue Li; Jinjiao Wang; Helena Temkin-Greener Journal: J Am Med Dir Assoc Date: 2020-10-26 Impact factor: 4.669